Insulin resistance blunts endothelial PI3K–Akt–eNOS signaling and nitric oxide (NO) bioavailability while upregulating endothelin-1–mediated vasoconstriction; concurrent dyslipidemia and hyperglycemia fuel oxidative stress and advanced glycation, further quenching NO [116]. Here, AKT1 is linked to Insulin resistance.